Product news from the 05/22/07 news brief

May 22 2007

Merck announced that the FDA has approved a new dosage of Fosamax Plus D (alendronate sodium/cholecalciferol).

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.